Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
54
HZO Quote, Financials, Valuation and Earnings
Last price:
$27.75
Seasonality move
:
11.13%
Day range:
$28.24 - $29.13
52-week range:
$22.51 - $39.60
Dividend yield:
0%
P/E ratio:
17.37x
P/S ratio:
0.27x
P/B ratio:
0.66x
Volume:
126K
Avg. volume:
212.2K
1-year change:
-13.49%
Market cap:
$647.6M
Revenue:
$2.4B
EPS (TTM):
$1.65
Analysts' Opinion
-
Consensus RatingMarineMax has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $39.63, MarineMax has an estimated upside of 38.26% from its current price of $28.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $28.66.
Fair Value
-
According to the consensus of 10 analysts, MarineMax has 38.26% upside to fair value with a price target of $39.63 per share.
HZO vs. S&P 500
-
Over the past 5 trading days, MarineMax has underperformed the S&P 500 by -3.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
MarineMax does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MarineMax revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MarineMax reported revenues of $563.1M.
Earnings Growth
-
MarineMax earnings have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter MarineMax reported earnings per share of $0.17.
Enterprise value:
1.5B
EV / Invested capital:
0.73x
Price / LTM sales:
0.27x
EV / EBIT:
11.95x
EV / Revenue:
0.63x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-17.80x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
8.87x
Gross Profit (TTM):
$801.2M
Return On Assets:
1.49%
Net Income Margin (TTM):
1.57%
Return On Equity:
4%
Return On Invested Capital:
1.88%
Operating Margin:
4.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.4B | $2.4B | $594.6M | $563.1M | |
| Gross Profit | $805.8M | $835.3M | $801.2M | $203.7M | $193.2M | |
| Operating Income | $265.2M | $200.8M | $128.2M | $34.3M | $26.8M | |
| EBITDA | $284.6M | $241.8M | $172.7M | $48M | $38.2M | |
| Diluted EPS | $8.86 | $4.89 | $1.65 | $0.67 | $0.17 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $503.3M | $517.5M | $754M | $1.1B | $1.3B | |
| Total Assets | $775.3M | $1B | $1.4B | $2.4B | $2.6B | |
| Current Liabilities | $272.5M | $251.1M | $412.8M | $847M | $1.1B | |
| Total Liabilities | $319.9M | $412.9M | $570.1M | $1.5B | $1.6B | |
| Total Equity | $455.4M | $594.9M | $782.7M | $918.4M | $986.2M | |
| Total Debt | $152.2M | $75M | $180.2M | $960.1M | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $76.6M | -$222.2M | -$25.7M | -$25.3M | -$782K | |
| Cash From Investing | -$140.5M | -$576.4M | -$81.3M | -$12.3M | -$16.5M | |
| Cash From Financing | $73.1M | $770.4M | $128.5M | $13.6M | -$1.6M | |
| Free Cash Flow | $18.1M | -$287.6M | -$86.1M | -$41.9M | -$17.5M | |
HZO
Sector
Market Cap
$647.6M
$485.3M
Price % of 52-Week High
72.37%
72.99%
Dividend Yield
0%
0%
Shareholder Yield
--
3.59%
1-Year Price Total Return
-24.48%
-11.51%
Beta (5-Year)
1.866
0.971
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$29.37
200-day SMA
Sell
Level
$30.93
Bollinger Bands (100)
Sell
Level
29.19 - 33.31
Chaikin Money Flow
Buy
Level
16.5M
20-day SMA
Sell
Level
$30.93
Relative Strength Index (RSI14)
Sell
Level
40.26
ADX Line
Sell
Level
26.85
Williams %R
Buy
Level
-84.0646
50-day SMA
Sell
Level
$30.73
MACD (12, 26)
Sell
Level
-0.74
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
22.5M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9024)
Sell
CA Score
(Annual)
Level (-0.423)
Sell
Beneish M-Score
(Annual)
Level (-2.2117)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.7886)
Sell
Piotroski F Score
(Annual)
Level (2)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
Stock Forecast FAQ
In the current month, HZO has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The HZO average analyst price target in the past 3 months is $39.63.
-
Where Will MarineMax Stock Be In 1 Year?
According to analysts, the consensus estimate is that MarineMax share price will rise to $39.63 per share over the next 12 months.
-
What Do Analysts Say About MarineMax?
Analysts are divided on their view about MarineMax share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MarineMax is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is MarineMax's Price Target?
The price target for MarineMax over the next 1-year time period is forecast to be $39.63 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is HZO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MarineMax is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HZO?
You can purchase shares of MarineMax via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MarineMax shares.
-
What Is The MarineMax Share Price Today?
MarineMax was last trading at $27.75 per share. This represents the most recent stock quote for MarineMax. Yesterday, MarineMax closed at $28.66 per share.
-
How To Buy MarineMax Stock Online?
In order to purchase MarineMax stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
